Drug development platform could provide flexible, rapid and targeted antimicrobials
2021-04-21
(Press-News.org) When disease outbreaks happen, response time in developing and distributing treatments is crucial to saving lives. Unfortunately, developing custom drugs as countermeasures is often a slow and difficult process.
But researchers at the University of Colorado Boulder have created a platform that can develop effective and highly specific peptide nucleic acid therapies for use against any bacteria within just one week. The work is detailed in Nature Communications Biology and could change the way we respond to pandemics and how we approach increasing cases of antibiotic resistance globally.
The Facile Accelerated Specific Therapeutic (FAST) platform was created by Associate Professor Anushree Chatterjee and her team within the Department of Chemical and Biological Engineering. It can quickly produce new antibiotics for any system or disease - from highly adaptive microbial super bugs to radiation poisoning in astronauts - that are specifically designed to selectively target just the bacteria of interest. The paper demonstrates significant growth inhibition and other positive responses in resistant bacteria such as E. coli, which are adapting to current treatments much faster than new drugs can hit the market.
Traditional drug discovery methods usually take 10 or more years and are specific to one bug or another. That is because they are based on identifying molecules from one bacteria that can then be used against other bacteria to promote human health. Unfortunately, evolution over billions of years has resulted in bacteria strains today that are increasingly resistant to this kind of approach - aided in part by recent over prescription of antibiotics by doctors. FAST, on the other hand, can be used for any bug and enables speedy identification and testing of molecules that target new mechanisms in pathogens - getting ahead of that curve.
Kristen Eller, a PhD candidate in the Chatterjee Group, is the first author on the new paper. She said the FAST system utilizes bacteria's genetic makeup to design specific and targeted antibiotics that stop their natural means of producing essential proteins, causing them to die. She added that the platform also provides a unique strategy to deliver these treatments to bacteria that are traditionally hard to target because they reside within our own host cells. To get around this, the platform essentially utilizes bacteria's natural ability to invade our own cells and manipulates it instead to be a carrier of the therapeutic.
"The applications for the real world are immense in that we have created a platform - not just a single therapeutic," she said. "It is adaptive, dynamic and can be altered to target any bacterial species that is a threat while also being modulated to develop antivirals as needed."
Recently, another paper published in PNAS showed the use of the FAST platform to create novel antibiotics against a clinical isolate of carbapenem-resistant E. coli that was found to be resistant to pretty much all antibiotics.
Chatterjee said that last aspect is particularly important as particular strains evolve, change and become more resistant over time. The goal, she said, is to rapidly create tailored treatments specific to the region in question, the person seeking treatment or even the global health situation for example.
"The technology we use to treat these kinds of health issues has to be smart enough to keep up with evolving organisms and also quick enough to respond to real-time crisis," she said. "Within this platform there are multiple steps where you can design and create new drug targets, which is really key."
Chatterjee said the platform could eventually be modified to develop antivirals for treatment of common colds, the flu and most pressingly, COVID-19. For now, her team is working on collecting more data to develop potential COVID-19 treatments and beginning to work towards clinical trials.
"We need to think out of the box when it comes to keeping up with pathogens because they are always advancing and changing," she said. "If we can establish these processes and techniques now, then we will be much better prepared next time there is a pandemic or outbreak."
INFORMATION:
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-04-20
Researchers at the University of Jyväskylä highlight how the struggles caused by the COVID-19 pandemic can guide us towards an equitable use of our shared environment and a transition towards sustainability.
COVID-19 crisis has emphasized how poorly prepared humanity is to cope with global disasters and to face the new ecological norm under climate change, degraded ecosystems, and biodiversity loss. The final consequences of COVID-19 crisis on sustainability are not yet known. However, this crisis offers a unique opportunity to move towards a greener, ...
2021-04-20
Coral reefs around the world are under threat from rising sea temperatures, ocean acidification, disease and overfishing, among other reasons.
Tracking signs of stress and ill health is difficult because corals -- an animal host coexisting with algae, bacteria, viruses and fungi -- are dynamic organisms that behave differently depending on what's happening in their environment. Some scientists wonder if recording changes in coral movements over time could help with monitoring a coral reef's health.
This is not always a straightforward task. Some coral species wave and pulse in ...
2021-04-20
Just as e-cigarette ingredients can vary from one region to another, the health effects of vaping can have regional characteristics as well. A new study out of West Virginia University suggests that rural e-cigarette users are older--and often get sicker--than their urban counterparts.
Researchers with the WVU School of Medicine are investigating severe lung injuries occurring among e-cigarette users in rural Appalachia. In a recent study, Sunil Sharma--section chief of pulmonary/critical care and sleep medicine at the School of Medicine--and his colleagues present a case study of patients with EVALI (electronic cigarettes and vaping-associated lung injury) admitted to WVU hospitals from August 2019 to March 2020. ...
2021-04-20
Like a stern bodyguard for the central nervous sytem, the blood-brain barrier keeps out anything that could lead to disease and dangerous inflammation--at least when all is functioning normally.
That may not be the case in people with schizophrenia and other mental disorders, suggest new findings from a team led by researchers from the School of Veterinary Medicine, Perelman School of Medicine, and Children's Hospital of Philadelphia (CHOP). In these individuals, a more permissive barrier appears to allow the immune system to get improperly involved in the central nervous system, the researchers showed. The inflammation that arises likely contributes to the clinical manifestations of neuropsychiatric conditions.
"Our hypothesis was that, if the immune function of the blood-brain ...
2021-04-20
WASHINGTON -- Researchers have developed new x-ray optics that can be used to harness extremely fast pulses in a package that is significantly smaller and lighter than conventional devices used to modulate x-rays. The new optics are based on microscopic chip-based devices known as microelectromechanical systems (MEMS).
"Our new ultrafast optics-on-a-chip is poised to enable x-ray research and applications that could have a broad impact on understanding fast-evolving chemical, material and biological processes," said research team leader Jin Wang from the U.S Department of Energy's Argonne National Laboratory. "This could aid in the development of more efficient solar cells and batteries, advanced computer storage materials and devices, ...
2021-04-20
Engineered, autonomous machines combined with artificial intelligence have long been a staple of science fiction, and often in the role of villain like the Cylons in the "Battlestar Galactica" reboot, creatures composed of biological and engineered materials. But what if these autonomous soft machines were ... helpful?
This is the vision of a team of Penn State and U.S. Air Force researchers, outlined in a recent paper in Nature Communications. These researchers produced a soft, mechanical metamaterial that can "think" about how forces are applied to it and respond via programmed reactions. ...
2021-04-20
People who regularly use psychoactive substances report experiencing a variety of negative impacts since the COVID-19 pandemic began, including increased usage and fear of relapse or overdose, highlighting the need for improved supports and services, including better access to safe supply programs, according to a new CAMH survey published in the International Journal of Drug Policy.
"People who use drugs have been negatively impacted by the pandemic in ways that put them at greater risk for experiencing substance and health-related harms, including overdoses and a decreased ability to mitigate risk behaviours," ...
2021-04-20
Leesburg, VA, April 20, 2021--An award-winning Scientific Electronic Exhibit to be presented at the ARRS 2021 Virtual Annual Meeting found non-contrast pituitary MRI for central precocious puberty (CPP), growth hormone deficiency (GHD), and short stature (SS) has similar diagnostic yield compared to the standard contrast-enhanced protocol.
"Microadenomas, a common justification for contrast administration, may not influence management in this patient population," wrote first author Jennifer Huang of Vanderbilt University in Nashville, TN, adding "minimal inconvenience would be added for the few patients who would need to return for contrast-enhanced MRI for definitive diagnosis."
Huang and colleagues performed a retrospective review of pediatric pituitary MRI studies from 2010-2019 ...
2021-04-20
Leesburg, VA, April 20, 2021--An award-winning Scientific Electronic Exhibit to be presented at the ARRS 2021 Virtual Annual Meeting found no statistically significant threshold for increased renal transplant biopsy risk based on systolic (SBP), diastolic (DBP), or mean arterial (MAP) blood pressure alone.
"When these metrics are combined," first author Winston Wang of the Mayo Clinic Arizona cautioned, "the risk of complication is significantly higher when the SBP is >= 180 mm Hg, DBP is >= 95 mm Hg, and MAP is >= 116 mm Hg."
Wang and team's review of consecutive ...
2021-04-20
Researchers have found a causal link between caesarean section birth, low intestinal microbiota and peanut sensitivity in infants, and they report the effect is more pronounced in children of Asian descent than others, in a recently published paper in the journal of the American Gastroenterological Association.
"It's important to know what predicts or increases risk of food sensitivities because they predict which infants will go on to develop asthma and other types of allergies," said Anita Kozyrskyj, pediatrics professor in the University of Alberta's Faculty of Medicine & Dentistry ...
LAST 30 PRESS RELEASES:
[Press-News.org] Drug development platform could provide flexible, rapid and targeted antimicrobials
